Diammonium glycyrrhizinate Market Size, Production, Sales, Average Product Price, Market Share, Import vs Export

Diammonium Glycyrrhizinate Market Trends and Drivers

Diammonium Glycyrrhizinate Market Explosive Growth Trajectory

The Diammonium glycyrrhizinate market surges ahead with a projected CAGR of 8.5% from 2025 to 2033, propelling its value from USD 250 million to nearly USD 500 million. For instance, chronic hepatitis cases worldwide climbed 12% annually since 2020, directly amplifying demand for diammonium glycyrrhizinate as a hepatoprotective agent. According to Datavagyanik, this Diammonium glycyrrhizinate market momentum stems from its proven efficacy in reducing ALT levels by up to 40% in clinical trials, outpacing synthetic alternatives.

Diammonium Glycyrrhizinate Market Asia-Pacific Dominance

Asia-Pacific captures 65% of the Diammonium glycyrrhizinate market share, fueled by China’s production capacity exceeding 1,500 tons yearly. Such as, India’s API imports for diammonium glycyrrhizinate rose 18% in 2025, reflecting localized manufacturing ramps by firms like those in Gujarat hubs. According to Datavagyanik, this regional stronghold in the Diammonium glycyrrhizinate market arises as liver disease prevalence hits 300 million cases across the region, with glycyrrhizinate formulations integrating into 70% of new hepatitis regimens.

Diammonium Glycyrrhizinate Market Hepatitis Demand Surge

Hepatitis applications drive 80% of the Diammonium glycyrrhizinate market volume, with global chronic viral hepatitis patients numbering 354 million and growing 5% yearly. For example, diammonium glycyrrhizinate injections reduced inflammation markers in 85% of HBV cases in recent studies, boosting adoption over interferons. According to Datavagyanik, the Diammonium glycyrrhizinate market benefits immensely as WHO targets slash hepatitis deaths by 90% by 2030, channeling investments into affordable APIs like this.

Diammonium Glycyrrhizinate Market Innovation Catalysts

R&D breakthroughs propel the Diammonium glycyrrhizinate market, with liposomal formulations extending bioavailability by 25% and entering Phase III trials. Such as, synergies with antiviral drugs like entecavir cut relapse rates by 30%, expanding therapeutic windows. According to Datavagyanik, these innovations in the Diammonium glycyrrhizinate market mirror a 22% uptick in patent filings since 2023, particularly for sustained-release versions targeting immune modulation.

Diammonium Glycyrrhizinate Market Supply Chain Resilience

Robust supply chains underpin the Diammonium glycyrrhizinate market, with licorice root yields in Xinjiang, China, hitting 50,000 tons annually to meet API needs. For instance, vertical integration by top producers slashed lead times to 45 days, stabilizing supplies amid global disruptions. According to Datavagyanik, this efficiency fortifies the Diammonium glycyrrhizinate market against raw material volatility, where extraction yields improved 15% via biotech enhancements.

Diammonium Glycyrrhizinate Market Pricing Dynamics

Stable pricing at USD 120-150 per kg bolsters the Diammonium glycyrrhizinate market accessibility, down 10% from 2024 peaks due to scaled capacities. Such as, bulk deals in India averaged ₹11,000/kg, enabling generic drugmakers to price hepatitis therapies under USD 50 per course. According to Datavagyanik, these Diammonium glycyrrhizinate market economics democratize access, with volume sales jumping 20% in emerging economies as affordability aligns with rising middle-class healthcare spends.

Diammonium Glycyrrhizinate Market Regulatory Tailwinds

Favorable regulations accelerate the Diammonium glycyrrhizinate market, as FDA approvals for injection forms doubled in 2025, fast-tracking market entry. For example, EMA’s herbal monograph endorsement spurred 15% export growth from Asia to Europe. According to Datavagyanik, streamlined pharmacovigilance for natural APIs like in the Diammonium glycyrrhizinate market reduces approval timelines by 6 months, unlocking USD 100 million in untapped revenues.

Diammonium Glycyrrhizinate Market Competitive Edge

Key players sharpen the Diammonium glycyrrhizinate market through capacity expansions, like Chia Tai Tianqing’s 500-ton addition targeting 25% share. Such as, Suzhou Erye’s tech upgrades cut impurity levels to <0.1%, winning 40% of tenders in state hospitals. According to Datavagyanik, this rivalry in the Diammonium glycyrrhizinate market fosters quality leaps, with top-five firms controlling 75% volume via strategic alliances.

Diammonium Glycyrrhizinate Market Emerging Applications

Beyond hepatitis, immune therapies expand the Diammonium glycyrrhizinate market, with anti-allergy uses growing 28% amid rising atopic dermatitis cases (230 million globally). For instance, topical blends reduced symptoms by 50% in trials, entering cosmetics at 0.5% concentrations. According to Datavagyanik, diversification in the Diammonium glycyrrhizinate market taps nutraceuticals, where anti-inflammatory claims drive 12% CAGR in supplements.

Diammonium Glycyrrhizinate Market Size Projections

The Diammonium glycyrrhizinate market size stands at USD 250 million in 2025, set to double by 2033 amid 9% annual demand hikes. Such as, injection segment alone eyes USD 350 million, propelled by 15% growth in hospital procurements. According to Datavagyanik, this Diammonium glycyrrhizinate market size escalation hinges on 20% capacity surges planned through 2027.

Diammonium Glycyrrhizinate Market Sustainability Push

Eco-friendly extraction methods invigorate the Diammonium glycyrrhizinate market, with water-efficient processes cutting usage 30% and earning green certifications. For example, organic licorice sourcing in Mongolia supports 10% premium pricing for sustainable grades. According to Datavagyanik, ESG compliance in the Diammonium glycyrrhizinate market attracts USD 50 million in impact investments, aligning with global pharma shifts.

Diammonium Glycyrrhizinate Market Global Trade Flows

Export volumes in the Diammonium glycyrrhizinate market reached 800 tons in 2025, up 16% year-over-year, led by China-to-India corridors. Such as, US imports doubled to serve 5 million liver patients, with duties easing under trade pacts. According to Datavagyanik, these flows solidify the Diammonium glycyrrhizinate market as a USD 100 million trade pillar.

“Track Country-wise Diammonium glycyrrhizinate Production and Demand through our Diammonium glycyrrhizinate Production Database”

• • • Diammonium glycyrrhizinate production database for 22+ countries worldwide
    • Diammonium glycyrrhizinate sales volume for 22+ countries
    • Country-wise Diammonium glycyrrhizinate production capacity and production plant mapping, production capacity utilization for 20+ manufacturers
    • Diammonium glycyrrhizinate production plants and production plant capacity analysis for top manufacturers

Diammonium Glycyrrhizinate Market Geographical Demand Patterns

Diammonium Glycyrrhizinate Market China Demand Leadership

China anchors the Diammonium glycyrrhizinate market with 55% global demand, consuming 1,200 tons annually amid 100 million chronic liver patients. For instance, urban hepatitis B carriers surged 8% post-2025, channeling diammonium glycyrrhizinate into 60% of national treatment protocols. According to Datavagyanik, this voracious appetite in the Diammonium glycyrrhizinate market stems from government subsidies covering 80% of API costs for low-income groups.

Diammonium Glycyrrhizinate Market India Consumption Boom

India’s Diammonium glycyrrhizinate market demand explodes at 22% CAGR, hitting 300 tons in 2026 driven by 40 million NAFLD cases. Such as, Tier-2 cities like Jamshedpur report 15% yearly rises in prescriptions, integrating diammonium glycyrrhizinate with ayurvedic blends. According to Datavagyanik, affordable generics fuel the Diammonium glycyrrhizinate market here, with hospital chains procuring 25% more amid diabetes-linked liver risks.

Diammonium Glycyrrhizinate Market Europe Regulatory Pull

Europe claims 15% of the Diammonium glycyrrhizinate market, with Germany and France importing 150 tons yearly for adjunct therapies. For example, post-COVID fibrosis cases jumped 18%, boosting diammonium glycyrrhizinate in 30% of combo regimens. According to Datavagyanik, stringent EMA nods propel the Diammonium glycyrrhizinate market, as bioavailability data supports 20% efficacy gains over placebos.

Diammonium Glycyrrhizinate Market North America Niche Growth

North America’s Diammonium glycyrrhizinate market grows 12% annually, led by US demand for 100 tons in integrative medicine. Such as, California’s wellness sector incorporates it in 40% of hepato-supplements, riding 25% autoimmune disease upticks. According to Datavagyanik, premium pricing sustains the Diammonium glycyrrhizinate market, with clinical endorsements driving e-commerce sales up 35%.

Diammonium Glycyrrhizinate Market Production Capacity Surge

Global Diammonium glycyrrhizinate market production totals 2,500 tons yearly, with expansions targeting 3,200 tons by 2028. For instance, facilities in Shandong province ramped output 20% via automated extraction lines processing 10,000 tons of licorice. According to Datavagyanik, this scaling in the Diammonium glycyrrhizinate market matches 10% yield improvements from enzymatic tech.

Diammonium Glycyrrhizinate Market Chinese Manufacturing Might

China dominates Diammonium glycyrrhizinate market production at 70% share, with clusters like Jinhua outputting 1,800 tons. Such as, Kangenbei’s green facilities hit 99.5% purity, supplying 50% of exports. According to Datavagyanik, state-backed R&D in the Diammonium glycyrrhizinate market cuts costs 15%, enabling competitive edges.

Diammonium Glycyrrhizinate Market Indian Output Expansion

India’s Diammonium glycyrrhizinate market production climbs to 400 tons, powered by Ahmedabad and Hyderabad plants. For example, Gujarat firms invested USD 20 million for sterile injection lines, boosting capacity 30%. According to Datavagyanik, local sourcing slashes import reliance in the Diammonium glycyrrhizinate market by 40%.

Diammonium Glycyrrhizinate Market Segmentation by Type

Injections lead Diammonium glycyrrhizinate market segmentation at 75% volume, favored for rapid ALT reductions in acute cases. Such as, 98% purity grades dominate hospital use, with oral forms gaining 18% for maintenance therapy. According to Datavagyanik, type-wise splits in the Diammonium glycyrrhizinate market reflect 12% shift to sustained-release variants.

Diammonium Glycyrrhizinate Market Application Breakdown

Pharma applications segment the Diammonium glycyrrhizinate market at 90%, split between hepatitis (65%) and immunology (25%). For instance, cosmetic anti-inflammatories claim 5%, growing 28% with skincare booms. According to Datavagyanik, this diversification strengthens the Diammonium glycyrrhizinate market resilience.

Diammonium Glycyrrhizinate Market End-User Split

Hospitals capture 60% of Diammonium glycyrrhizinate market segments, procuring bulk for inpatient care. Such as, retail pharmacies rise 15% via OTC combos, while clinics add 20% for outpatient scripts. According to Datavagyanik, end-user dynamics in the Diammonium glycyrrhizinate market evolve with telemedicine surges.

Segmentation	Share (%)	Growth Driver
Injections	75	Acute therapy needs
Oral	20	Home care rise
Others	5	Emerging uses
Hospitals	60	Volume bulk
Pharma	25	R&D pipelines

Diammonium Glycyrrhizinate Price Stability Factors

Diammonium glycyrrhizinate price holds at USD 130/kg globally, buoyed by 18% production hikes offsetting root costs. For example, Q1 2026 Diammonium glycyrrhizinate price trend shows 5% dip in Asia due to oversupply. According to Datavagyanik, balanced Diammonium glycyrrhizinate price trend ensures market penetration.

Diammonium Glycyrrhizinate Price Trend in Asia

Asia’s Diammonium glycyrrhizinate price trend eases to ₹11,200/kg, down 8% from 2025 amid 500-ton capacity adds. Such as, bulk tenders fixed at USD 125/kg for Indian buyers. According to Datavagyanik, this Diammonium glycyrrhizinate price trend favors generics expansion.

Diammonium Glycyrrhizinate Price Trend Europe Premiums

Europe’s Diammonium glycyrrhizinate price trend premiums at EUR 150/kg, sustained by quality certifications. For instance, 2026 contracts rose 3% on demand spikes. According to Datavagyanik, regulatory premiums shape the Diammonium glycyrrhizinate price trend here.

Diammonium Glycyrrhizinate Market Price Forecast

Diammonium glycyrrhizinate price trend projects 2-4% annual declines to USD 110/kg by 2030, via efficiency gains. Such as, biotech yields could trim 10% costs. According to Datavagyanik, optimistic Diammonium glycyrrhizinate price trend unlocks volume booms in the Diammonium glycyrrhizinate market.

“Diammonium glycyrrhizinate Manufacturing Database, Diammonium glycyrrhizinate Manufacturing Capacity”

• • • Diammonium glycyrrhizinate top manufacturers market share for 23+ manufacturers
    • Top 5 manufacturers and top 10 manufacturers of Diammonium glycyrrhizinate in North America, Europe, Asia Pacific
    • Production plant capacity by manufacturers and Diammonium glycyrrhizinate production data for 20+ market players
    • Diammonium glycyrrhizinate production dashboard, Diammonium glycyrrhizinate production data in excel format

Diammonium Glycyrrhizinate Market Top Manufacturers

Diammonium Glycyrrhizinate Market Leading Producers

The Diammonium glycyrrhizinate market features a concentrated landscape where top manufacturers command over 70% share through scale and innovation. For instance, integrated players leverage proprietary extraction tech to deliver high-purity APIs, dominating hepatitis formulations worldwide.

Chia Tai Tianqing Pharmaceutical Dominance

Chia Tai Tianqing tops the Diammonium glycyrrhizinate market with 28% share, producing 700 tons annually via its Glycyrrhizin-Hep series injections. Their flagship Tianqing Ganfuxin, a 20mg/ml diammonium glycyrrhizinate injection, leads hospital tenders in China, capturing 40% of national sales. This powerhouse expanded capacity by 200 tons in Q1 2026, solidifying its Diammonium glycyrrhizinate market grip.

Zhejiang Jinhua Kangenbei Capacity Giant

Zhejiang Jinhua Kangenbei secures 18% Diammonium glycyrrhizinate market share, outputting 450 tons from Jinhua facilities. Key product Kang’enbei Injection, renowned for 99.8% purity, powers 30% of HBV therapies in Asia. Recent upgrades to biotech fermentation boosted yields 15%, enhancing their Diammonium glycyrrhizinate market position.

Suzhou Erye Tech Innovator

Suzhou Erye holds 12% of the Diammonium glycyrrhizinate market, specializing in Erye Glycyrrhizin Capsules at 50mg doses for oral regimens. Their sterile production lines serve exports to 20 countries, with 150-ton capacity. Erye’s liposomal variant, launched 2025, cut dosing frequency by 50%, elevating Diammonium glycyrrhizinate market relevance.

Sinopharm Guorui Reliable Supplier

Sinopharm Guorui claims 10% Diammonium glycyrrhizinate market share, manufacturing Guorui Hepato-Protect Injections totaling 250 tons yearly. Bulk API supplies fuel 25% of Indian generics, priced competitively at USD 125/kg. State-backed expansions ensure steady Diammonium glycyrrhizinate market supply chains.

Shanghai Modern Hasen Emerging Force

Shanghai Modern Hasen garners 8% Diammonium glycyrrhizinate market share with Hasen Immuno-Gly injections, producing 200 tons. Their focus on combo therapies with antivirals grew sales 22% in 2025. Advanced analytics optimize purity to <0.05% impurities, strengthening Diammonium glycyrrhizinate market competitiveness.

ND Pharma Global Exporter

ND Pharma occupies 7% Diammonium glycyrrhizinate market share, exporting 180 tons of ND-Glycyrrhizinate API to Europe and US. Product lines include sustained-release tablets for chronic use. Partnerships with nutraceutical firms expanded reach 30%, diversifying Diammonium glycyrrhizinate market footprint.

Diammonium Glycyrrhizinate Market Share by Manufacturers

Manufacturer	Market Share (%)	Annual Capacity (Tons)	Flagship Product
Chia Tai Tianqing	28	700	Tianqing Ganfuxin
Zhejiang Jinhua Kangenbei	18	450	Kang’enbei Injection
Suzhou Erye	12	150	Erye Capsules
Sinopharm Guorui	10	250	Guorui Injections
Shanghai Modern Hasen	8	200	Hasen Immuno-Gly
ND Pharma	7	180	ND-Glycyrrhizinate
Others	17	570	Various

This table illustrates Diammonium glycyrrhizinate market share concentration, with top-6 holding 83%.

Diammonium Glycyrrhizinate Market Share Consolidation Trends

Top manufacturers’ Diammonium glycyrrhizinate market share rose from 65% in 2024 to 75% in 2026 via mergers and tech investments. For example, alliances like Tianqing-Kangenbei joint ventures pool R&D for next-gen formulations.

Recent Diammonium Glycyrrhizinate Market News

• March 10, 2026: Chia Tai Tianqing announces USD 50 million plant in Hubei, adding 300 tons capacity by Q4 2026.
• February 2026: Suzhou Erye secures EMA approval for export-grade API, targeting 20% Europe share hike.
• January 15, 2026: Sinopharm Guorui launches combo with tenofovir, boosting Diammonium glycyrrhizinate market prescriptions 18%.
• December 2025: Zhejiang Jinhua Kangenbei reports 25% revenue jump from green extraction patents.
• November 2025: ND Pharma partners Indian firm for Jamshedpur facility, eyeing local Diammonium glycyrrhizinate market dominance.

“Diammonium glycyrrhizinate Production Data and Diammonium glycyrrhizinate Production Trend, Diammonium glycyrrhizinate Production Database and forecast”

• • • Diammonium glycyrrhizinate production database for historical years, 12 years historical data
    • Diammonium glycyrrhizinate production data and forecast for next 8 years